Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

rx:cc

POPULAR ARTICLES

BioSyent Declares Third Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares Third Quarter 2026 Dividend

BioSyent Releases Financial Results for Q2 and H1 2026

pharmaceutical investing

BioSyent Releases Financial Results for Q2 and H1 2026

BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026

pharmaceutical investing

BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026

LATEST ARTICLES

BioSyent to Present at Planet MicroCap Las Vegas

pharmaceutical investing

BioSyent to Present at Planet MicroCap Las Vegas

BioSyent Declares Second Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares Second Quarter 2026 Dividend

BioSyent Releases Financial Results for First Quarter 2026

pharmaceutical investing

BioSyent Releases Financial Results for First Quarter 2026

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

pharmaceutical investing

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

pharmaceutical investing

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

pharmaceutical investing

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

BioSyent Announces Grant of Restricted Share Units

pharmaceutical investing

BioSyent Announces Grant of Restricted Share Units

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

pharmaceutical investing

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

pharmaceutical investing

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

pharmaceutical investing

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

BioSyent to Acquire Oral Science Inc.

pharmaceutical investing

BioSyent to Acquire Oral Science Inc.

BioSyent Declares First Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares First Quarter 2026 Dividend

Latest News

New Found Gold Declares Commercial Production at Hammerdown Gold Mine

Westport Enters Into Committed Equity Facility of up to US$25 Million

Valeura Energy Inc Announces "Suraphi" Exploration Discovery

Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources

Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Pan Global Resources

Pan Global Resources (PGZ:CC)

PGZ:CC

Sirios Resources

Sirios Resources (SOI:CC)

SOI:CC

Bahia Metals

BMT:CC

TomaGold

TomaGold (LOT:CC)

LOT:CC

Red Metal Resources

Red Metal Resources (RMES:CC)

RMES:CC

Oreterra Metals

Oreterra Metals (OTMC:CC)

OTMC:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES